Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.051 | 0.7 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.7 |
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |